Yoo Sung Song
Papers
1
Total Citations
7
H-Index
1
About
Yoo Sung Song is a leading researcher in the field of oncologic imaging, with a primary focus on advancing the diagnostic capabilities of hybrid imaging for prostate cancer. His most-cited work, "Diagnostic accuracy of F-18-Fluorocholine PET/CT and multiparametric MRI for prostate cancer" (2022, 7 citations), represents a significant contribution to the comparative evaluation of novel metabolic imaging tools. In this study, Song rigorously assessed the diagnostic efficacy of F-18-Fluorocholine positron emission tomography/computed tomography (PET/CT) against the established standard of multiparametric MRI, providing critical evidence for the integration of PET-based radiopharmaceuticals into clinical workflows. By systematically analyzing the accuracy of these modalities, his research helps clarify the role of emerging molecular imaging techniques in improving prostate cancer detection and staging. Though early in its citation history, this work has already informed ongoing discussions about optimizing non-invasive diagnostic pathways. Song’s dedication to refining imaging protocols and validating new tracers underscores his commitment to enhancing precision medicine in oncology, making his research a valuable resource for clinicians and radiologists seeking to improve patient outcomes through advanced imaging technologies.
Research Focus
Key Achievements
Top Papers
- 1